Sharemaestro Newsreel

Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Apyx Medical Corp (APYX), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 5 analysts, the stock has a "Buy" trend with an average price target of $5.00. The company's expected revenue …

Alphatec Holdings, Inc. (NASDAQ:ATEC) Just Reported Second-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?

Alphatec Holdings recently reported its second-quarter earnings, leading to analysts updating their price targets and earnings forecasts for the company. While sales beat expectations, earnings per share missed targets, resulting in a slight reduction in the consensus price target. The article examines the sentiment …

Apyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary

Apyx Medical Corp (APYX) reported its 2026 quarterly results, with revenue increasing to $13.88M from $11.37M year-over-year. The company posted a net loss of ($3.24M) and a diluted loss per share of ($0.07), showing an improvement from the prior year. This performance was largely …

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates

Treace Medical Concepts (TMCI) Reports Q2 Loss, Tops Revenue Estimates

Adagio Medical Company Profile & Introduction

This document provides a company profile and introduction for Adagio Medical. It outlines the company's background, key operations, and overall business focus, serving as a foundational overview for understanding its market position and strategic direction.

Baird Medical Investment Holdings Ltd (BDMD) Stock News Today

This article provides current stock information for Baird Medical Investment Holdings Ltd (BDMD), including its latest price, market capitalization, and a note that more news is coming soon. As of August 7, the stock closed at $1.250, up 5.93%. The page also offers various …

FNY Investment Advisers LLC Purchases New Stake in Avanos Medical, Inc. $AVNS

FNY Investment Advisers LLC has acquired a new stake in Avanos Medical, Inc. (NYSE:AVNS), purchasing 103,500 shares valued at approximately $2.575 million, which now represents 0.9% of FNY’s holdings and 0.22% of Avanos Medical. Other institutional investors have also adjusted their positions in AVNS. …

Abbott (ABT) Stock Trades At A Cash Flow Discount But An Earnings Premium

Abbott Laboratories' stock has dropped 16.4% over the past year, but a Discounted Cash Flow (DCF) analysis suggests a 28.1% upside compared to its current share price, indicating it's undervalued based on future cash flow potential. However, its P/E ratio of 34.6x is higher …

Treace Medical Q2 revenue falls 4 percent to $45.4 million

Wilsey Asset Management Inc. Has $36.32 Million Stake in Zimmer Biomet Holdings, Inc. $ZBH

Wilsey Asset Management Inc. increased its stake in Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 4.7% in the second quarter, bringing its total holdings to 421,867 shares valued at $36.32 million. The medical equipment provider recently reported strong Q2 earnings, beating analyst estimates with $2.18 …

ETFs Investing in Alphatec Holdings, Inc. Stocks

This article lists various ETFs that invest in Alphatec Holdings, Inc. (ATEC) stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, and performance metrics for each fund. The funds primarily target small-cap and healthcare sectors, indicating ATEC's …

What Alphatec Holdings (ATEC)'s Reaffirmed 2026 Outlook and Narrowing Losses Mean For Shareholders

Alphatec Holdings (ATEC) has reported its Q2 and H1 2026 results, showing reduced net losses and reaffirming its full-year 2026 revenue guidance of approximately US$882 million. This positive outlook, driven by increasing surgeon adoption and procedural volumes, supports the company's investment narrative toward profitability …

IRTC Looks 22.6% Undervalued on GF Value™

iRhythm Technologies, Inc. (IRTC) reported strong Q2 revenue growth of 20.1% year-over-year, leading to raised full-year guidance and a strategic acquisition to expand its cardiac monitoring capabilities. Despite being unprofitable, the company is considered 22.6% undervalued based on its GF Value™ and shows strong …

Palouse Capital Management Inc. Acquires 29,275 Shares of Medtronic PLC $MDT

Palouse Capital Management Inc. significantly increased its stake in Medtronic PLC (NYSE:MDT) during the second quarter, acquiring an additional 29,275 shares to bring its total holdings to 57,027 shares valued at approximately $4.46 million. This move comes as Medtronic exceeded analyst expectations with its …

Rapid Micro Biosystems Marks 200th Growth Direct System Placement

Boston Scientific Corporation (NYSE:BSX) Just Reported, And Analysts Assigned A US$62.69 Price Target

Viemed Healthcare (NASDAQ:VMD) Stock Rating Lowered by Freedom Capital

Freedom Capital downgraded Viemed Healthcare (NASDAQ:VMD) from a "strong buy" to a "hold" rating, while Weiss Ratings simultaneously upgraded it to a "buy." Despite the conflicting ratings, MarketBeat's consensus remains "Hold." The company recently reported Q2 EPS of $0.07, missing analyst estimates, but revenue …

Avita Medical Shares Surge After Record Second-Quarter Performance

Avita Medical stock rating upgraded to buy at BTIG on revenue beat

Treace Medical Concepts, Inc. (TMCI) Stock Analysis: Navigating Challenges with Innovative Medical Solutions

Treace Medical Concepts (TMCI) is a healthcare company innovating in bunion and foot deformity correction with products like the Lapiplasty System. Despite financial challenges including negative revenue growth and ROE, the company's unique product offerings present potential for investors. Its stock shows volatility, and …

InMode Ltd. (INMD) Stock Analysis: Evaluating Growth Potential in the Medical Device Sector

This article analyzes InMode Ltd. (INMD), an Israel-based medical device company specializing in minimally invasive aesthetic treatments. It evaluates the company's financial performance, stock indicators, and market position, noting its innovative technology and strong free cash flow despite stagnant revenue growth. The analysis concludes …

Modular Medical Inc (MODD) Earnings Forecast: Future EPS & Revenue Growth Estimates

Why is Avita Medical stock surging 20% today?

QuidelOrtho Corp Quarterly Earnings Report

QuidelOrtho Corp (QDEL) has released its unaudited quarterly report for the period ended June 28, 2026, detailing a completed acquisition of LEX Diagnostics for $174.6 million, increased borrowings of $2,891.1 million, and a new equity award of 356,555 restricted stock units to its new …

SANUWAVE Health, Inc. Q2 2026: Revenue $9.74M, EPS $(0.08) — 10-Q Summary

SANUWAVE Health, Inc. reported its Q2 2026 financial results, showing a decline in revenue to $9.74M from $10.05M in the prior year and a net loss of $0.682M compared to a net income of $0.551M year-over-year. Diluted EPS also decreased from $0.06 to $(0.08). …

Haemonetics Corp (HAE) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Haemonetics Corp (HAE), detailing its current price momentum score of 4.19 and its trading range between a resistance level of $91.33 and a support level of $75.97. It evaluates various technical indicators, including MACD, RSI, and moving …

Earnings To Watch: TELA Bio Inc (TELA) Q2 2026 -- GF Value Sees 97% Upside

TELA Bio Inc (TELA) is scheduled to release its Q2 2026 earnings on August 10, 2026, with revenue estimates at $20.01 million and earnings expected at -$0.18 per share. Despite a decline in full-year 2026 and 2027 revenue and earnings estimates, the company's Q1 …

Globus Medical (NYSE:GMED) Beats Q2 CY2026 Sales Expectations

Globus Medical (NYSE:GMED) Beats Q2 CY2026 Sales Expectations Medical device company Globus Medical (NYSE:GMED) announced better-than-expected revenue in Q2 CY2026, with sales up 5.9% year on year to $789.6 million. The company expects the full year's revenue to be around $3.2 billion, close to …

Profound Medical Corp (PROF) Earnings Forecast: Future EPS & Revenue Growth Estimates

Profound Medical (PROF) reported Q2 earnings of $0.26 per share, significantly surpassing the Zacks Consensus Estimate of a loss of $0.22 per share. While the company beat EPS estimates, its revenues of $2.48 million for the quarter missed the consensus estimate by 55.66%. The …

QT Imaging Holdings Inc (QTI) Earnings Forecast: Future EPS & Revenue Growth Estimates

Co-Diagnostics' Test Filing Draws on 1,400 Patients

Co-Diagnostics (Nasdaq: CODX) has submitted a Dual FDA 510(k) premarket notification and a concurrent CLIA Waiver by Application for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test. This test is designed for use on the Co-Dx PCR Pro instrument in decentralized …

Co-Diagnostics submits FDA 510(k) for respiratory test

Co-Diagnostics, Inc. has submitted a Dual 510(k) premarket notification and a concurrent CLIA Waiver by Application to the FDA for its Co-Dx PCR Flu A/B & RSV upper respiratory multiplex test. This submission aims to allow the test to be used in decentralized point-of-care …

LENSAR Inc (LNSR) Stock News Today

This article provides current stock information for LENSAR Inc (LNSR), including its stock price, market capitalization, and P/E ratio. It indicates that more news regarding the company's stock, earnings, and analyst ratings will be available soon. The page serves as a hub for financial …

Sera Prognostics (SERA) Q1 2026 Earnings: EPS Matches Estimates at -$0.17, Stock Flat - Guidance Upgrade Report

How Does electroCore Inc (ECOR) Measure Up After Q2 Earnings? EP